Orbus Neich Says Boston Scientific Corporation (BSX) is Misleading Preliminary Court Injunction
5/14/2013 8:20:29 AM
More...
|
Orbus Neich's Genous(TM) Stent Shows Favorable Outcomes for Treatment of Coronary Artery Bifurcation Lesions Compared to Bare Metal Stents
12/2/2010 11:28:54 AM
More...
|
Orbus Neich Issues Statement on Boston Scientific Corporation (BSX)'s Unsuccessful Retaliatory Litigation Efforts in the Netherlands
12/1/2010 7:27:57 AM
More...
|
Unique Studies with Orbus Neich's Genous(TM) Stent Further Validate Early Endothelial Progenitor Cell Coverage and Reduced Thrombogenicity in Human Circulating Blood Compared to Bare Metal Stents
11/23/2010 10:42:19 AM
More...
|
Randomized Clinical Trial of Orbus Neich's Genous(TM) Bio-engineered R Stent(TM) in China Completes Patient Enrollment
10/11/2010 10:06:52 AM
More...
|
Data from Multiple Clinical Trials of Orbus Neich's Genous(TM) Bio-engineered R Stent(TM) Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010
9/27/2010 8:28:11 AM
More...
|
Orbus Neich's Genous(TM) Bio-engineered R Stent(TM) Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease
9/24/2010 8:43:17 AM
More...
|
Patient Enrollment Completed in First Randomized Clinical Study of Orbus Neich's Combo(TM) Bio-engineered Sirolimus Eluting Stent
9/24/2010 8:36:33 AM
More...
|
100 Percent Coverage of Struts and Complete Neointimal Coverage of Orbus Neich's Genous(TM) Bio-engineered R Stent(TM) Demonstrated 26 Days Post-Implantation in STEMI Patient
8/23/2010 11:13:23 AM
More...
|
Data Show Orbus Neich's Genous(TM) Bio-engineered R stent(TM) is Safe and Effective in Combination with Drug-Eluting Balloon
6/22/2010 10:42:38 AM
More...
|
|